International Stem Cell Corporation to Host Third Quarter 2014 Business Update and Financial Results Conference Call at 11:00 am ET on Friday, November 14, 2014
November 07, 2014 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - November 07, 2014) - International Stem Cell Corporation (OTCQB: ISCO) a California-based biotechnology company developing novel stem cell based therapies and biomedical...
FDA Clears ISCO's Stem Cell Line for Clinical Uses
November 04, 2014 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - November 04, 2014) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical...
International Stem Cell Corporation's CEO Publishes Letter to Shareholders
November 03, 2014 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - November 03, 2014) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical...
International Stem Cell Corporation to Raise $2.5 Million Through a Private Placement
October 08, 2014 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - October 08, 2014) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical...
International Stem Cell Corporation Provides Update on the Status of Its Parkinson's Disease Program
October 02, 2014 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - October 02, 2014) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical...
International Stem Cell Corporation to Present at Two Upcoming Investment Conferences
August 28, 2014 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - August 28, 2014) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell...
International Stem Cell Corporation Provides R&D and Business Results for Second Quarter and First Half of 2014
August 12, 2014 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - August 12, 2014) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical...
International Stem Cell Corporation to Host Second Quarter 2014 Business Update and Financial Results Conference Call at 11:00 am ET on Tuesday, August 12, 2014
August 07, 2014 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - August 07, 2014) - International Stem Cell Corporation (OTCQB: ISCO) a California-based biotechnology company developing novel stem cell based therapies and biomedical...
International Stem Cell Corporation Launches Stroke Program With Tulane University
August 05, 2014 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - August 05, 2014) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company...
International Stem Cell Corporation Secures Approval for Core Technology Patents in European Union
July 22, 2014 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - July 22, 2014) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company...